Boryung Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Boryung yıllık ortalama 11.3% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 11.7% annual. Gelirler growing yılda ortalama 13.2% oranında artmaktadır. Boryung'in özkaynak karlılığı 10.9% ve net marjı 7%'dir.

Anahtar bilgiler

11.3%

Kazanç büyüme oranı

7.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi	11.3%
Gelir büyüme oranı	13.2%
Özkaynak getirisi	10.9%
Net Marj	7.0%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10

Recent updates

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23

Gelir ve Gider Dağılımı

Boryung nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

KOSE:A003850 Gelir, gider ve kazançlar (KRW Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Jun 24	928,718	64,579	223,422	52,073
31 Mar 24	889,416	52,254	220,641	50,585
31 Dec 23	859,626	40,203	214,854	47,286
30 Sep 23	829,854	28,267	201,656	41,603
30 Jun 23	819,463	38,284	200,154	41,415
31 Mar 23	785,679	42,063	195,427	40,249
31 Dec 22	760,476	41,894	191,858	41,705
30 Sep 22	724,659	53,911	184,422	43,444
30 Jun 22	694,170	52,524	178,676	41,373
31 Mar 22	661,948	34,380	173,972	40,604
31 Dec 21	627,279	43,044	171,818	39,146
30 Sep 21	600,008	41,823	167,985	36,053
30 Jun 21	587,350	28,892	167,011	35,884
31 Mar 21	571,594	38,370	159,083	36,957
31 Dec 20	561,867	26,856	148,224	35,506
30 Sep 20	562,433	27,744	144,704	36,253
30 Jun 20	546,974	27,969	140,383	39,247
31 Mar 20	539,742	31,678	140,141	36,934
31 Dec 19	524,269	32,222	139,544	37,864
30 Sep 19	498,006	32,950	127,560	36,683
30 Jun 19	480,242	29,886	124,855	34,458
31 Mar 19	467,445	22,830	125,221	35,580
31 Dec 18	460,402	20,307	122,204	34,433
30 Sep 18	441,580	64,630	107,695	58,302
30 Jun 18	440,087	62,855	115,359	49,298
31 Mar 18	434,565	60,451	127,963	32,997
31 Dec 17	422,721	56,699	127,666	32,277
30 Sep 17	426,554	-3,202	145,023	7,366
30 Jun 17	423,777	-2,977	137,328	14,638
31 Mar 17	420,133	5,020	120,819	29,164
31 Dec 16	409,140	5,614	121,778	28,963

Kaliteli Kazançlar: A003850 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: A003850 'nin mevcut net kar marjları (7%) geçen yılın (4.7%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A003850 şirketinin kazancı son 5 yılda yılda 11.3% oranında arttı.

Büyüme Hızlandırma: A003850 'un son bir yıldaki kazanç büyümesi ( 68.7% ) 5 yıllık ortalamasını (yıllık 11.3% ) aşıyor.

Kazançlar vs. Sektör: A003850 geçen yılki kazanç büyümesi ( 68.7% ) Pharmaceuticals sektörünün 21.9% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: A003850 'nin Özsermaye Getirisi ( 10.9% ) düşük olarak değerlendiriliyor.

Boryung Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

First quarter 2021 earnings released: EPS ₩400 (vs ₩180 in 1Q 2020)

Full year 2020 earnings released: EPS ₩554 (vs ₩698 in FY 2019)

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Recent updates

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Investor sentiment improves as stock rises 18%

Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Full year 2023 earnings: EPS misses analyst expectations

Boryung Corporation, Annual General Meeting, Mar 26, 2024

Upcoming dividend of ₩100.00 per share at 0.9% yield

Boryung Corporation(KOSE:A003850) dropped from KOSPI 200 Index

Investor sentiment improves as stock rises 17%

New major risk - Revenue and earnings growth

Boryung Corporation Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans in Space" Program

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₩100.00 per share

Less than half of directors are independent

Price target decreased to ₩15,500

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Upcoming dividend of ₩75.77 per share

Price target increased to ₩17,500

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₩400 (vs ₩180 in 1Q 2020)

Investor sentiment deteriorated over the past week

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Full year 2020 earnings released: EPS ₩554 (vs ₩698 in FY 2019)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Boryung Pharmaceutical Co., Ltd., Annual General Meeting, Mar 26, 2021

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

New 90-day high: ₩20,500

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Market pulls back on stock over the past week

Price target raised to ₩21,000

New 90-day high: ₩20,700

Market bids up stock over the past week

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Third quarter 2020 earnings released: EPS ₩168

New 90-day low: ₩14,750

New 90-day low: ₩15,250

Price target raised to ₩21,000

First half earnings released

New 90-day high - ₩17,550

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin